{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["11(1)"],"submitter":["Tadege M"],"pubmed_abstract":["<h4>Objective</h4>The purpose of this study was to identify the major risk factors, which contributed to shortened survival time to death of HIV patients on antiretroviral therapy. Six-hundred HIV patients were included from two hospitals and six health centers record from January 2003 to December 2017. Kaplan-Meier and Cox proportional hazard model were implemented.<h4>Results</h4>From the Kaplan-Meier, log-rank test result indicated that there was a significant difference between tuberculosis comorbidity (P = .000), occupation (P = .027), and WHO clinical stage (P = .012) on the survival experience of patients at 5% statistical significance level. From the Cox regression result, the risk of death for patients who lived with tuberculosis was about 2.872-fold times higher than those patients who were negative. Most of the HIV/AIDS patients on antiretroviral therapy were died in a short period due to tuberculosis comorbidity, began with lower amount of CD4, being underweight, merchant, and being on WHO clinical stage IV."],"journal":["BMC research notes"],"pagination":["761"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6202867"],"repository":["biostudies-literature"],"pubmed_title":["Time to death predictors of HIV/AIDS infected patients on antiretroviral therapy in Ethiopia."],"pmcid":["PMC6202867"],"pubmed_authors":["Tadege M"],"additional_accession":[]},"is_claimable":false,"name":"Time to death predictors of HIV/AIDS infected patients on antiretroviral therapy in Ethiopia.","description":"<h4>Objective</h4>The purpose of this study was to identify the major risk factors, which contributed to shortened survival time to death of HIV patients on antiretroviral therapy. Six-hundred HIV patients were included from two hospitals and six health centers record from January 2003 to December 2017. Kaplan-Meier and Cox proportional hazard model were implemented.<h4>Results</h4>From the Kaplan-Meier, log-rank test result indicated that there was a significant difference between tuberculosis comorbidity (P = .000), occupation (P = .027), and WHO clinical stage (P = .012) on the survival experience of patients at 5% statistical significance level. From the Cox regression result, the risk of death for patients who lived with tuberculosis was about 2.872-fold times higher than those patients who were negative. Most of the HIV/AIDS patients on antiretroviral therapy were died in a short period due to tuberculosis comorbidity, began with lower amount of CD4, being underweight, merchant, and being on WHO clinical stage IV.","dates":{"release":"2018-01-01T00:00:00Z","publication":"2018 Oct","modification":"2025-04-20T00:09:17.715Z","creation":"2019-03-27T00:05:27Z"},"accession":"S-EPMC6202867","cross_references":{"pubmed":["30359289"],"doi":["10.1186/s13104-018-3863-y"]}}